Resolute Capital Asset Partners’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-39,500	Closed	-$1.14M	–	59
2024 Q1	$1.14M	Buy	+39,500	New	+$1.14M	0.6%	39
2022 Q1	–	Sell	-55,000	Closed	-$1.88M	–	54
2021 Q4	$1.88M	Buy	+55,000	New	+$1.88M	1.23%	33